Introduction {#sec1}
============

Sexual dimorphism in health and disease {#sec1-1}
---------------------------------------

Sexual dimorphism is the differentiation between the male and female sexes in both morphology and phenotype. So-called primary sex traits, such as the male and female sex organs and reproductive traits, are evidently sexually dimorphic. Other sexually dimorphic characteristics in animals are visually striking: the elaborate tail of the male peacock, the male lion's mane and the increased body size of some female spiders \[[@B1]\]. Animal models have helped reveal additional biological sexually dimorphic characteristics, including sex-specific neural circuitry in flies \[[@B2],[@B3]\] and sex-specific gene expression in mammals \[[@B2],[@B4]\].

Despite centuries of observation of such sexually dimorphic characteristics and features, little is understood about the aetiology of sexually dimorphic traits. The sex chromosomes are an obvious first culprit in identifying biological drivers of sexual dimorphism in animals. Males can exhibit recessive diseases carried on the X chromosome; an example is red-green colour blindness, an X-linked disease that is one of the most prevalent sexually dimorphic traits (prevalence approximately 5% in males and \<1% in females) \[[@B5]\]. Female carriers of recessive X-linked diseases are not necessarily unaffected by the disease allele; these female carriers of X-linked disease mutations can have altered X-chromosome inactivation \[[@B2]\] and can also demonstrate diminished severity of disease \[[@B2],[@B6]\].

The X chromosome is not the only biological regulator of sexually dimorphic characteristics. The role of the autosomal genome is also crucial when considering the genetic architecture of sexually dimorphic traits. On a molecular level, several species have been shown to have sexually dimorphic gene expression across the genome and across tissues and organs \[[@B2]\]. Additionally, a recent investigation of common genetic variants (or single nucleotide polymorphisms, called SNPs) \[[@B7]\] indicated that many genes across the human genome are undergoing sex-specific selection, selection that results in biased gene expression between males and females; this observation was also replicated in data drawn from flies \[[@B8]\], suggesting a mechanism conserved across species. It remains difficult, however, to pinpoint precisely when this selection occurs and its downstream phenotypic effect on both anthropometric traits and on health and diseases more generally.

Body fat distribution and sexual dimorphism {#sec1-2}
-------------------------------------------

Beyond the immediate benefit of enabling sexual reproduction, sexually dimorphic traits may bestow their carriers with particular advantages. For example, it is hypothesized that "ornamental" \[[@B1],[@B9]\] males may make more advantageous mates, as they are more likely to provide particular benefits such as physical protection or care to a pregnant partner \[[@B1],[@B9]\]. Though sexual dimorphism may confer health and reproductive benefits, it has also been observed in a wide range of common diseases in animals (both human and nonhuman) that are complex in aetiology, including both an environmental and a biological component. In children, for example, autism is more common in boys, whereas scoliosis is more common in girls \[[@B2]\]. Sexual dimorphism persists in later onset diseases as well: Parkinson's disease, schizophrenia \[[@B2]\] and amyotrophic lateral sclerosis are all more common in men \[[@B10]\], whereas women are at a higher risk of autoimmune diseases, major depression \[[@B2]\] and hypertension \[[@B11]\].

Body composition and fat distribution are also complex traits that have been observed to be sexually dimorphic in both humans and nonhumans, particularly in (nonhuman) animal models \[[@B12]\]. There are numerous ways to measure body composition and fat distribution including, but not limited to: body mass index (BMI), height, weight, waist-to-hip ratio (WHR), waist circumference (WC) and hip circumference (often denoted as simply "HIP"). Many of these traits are closely linked. For example, BMI or overall obesity is significantly correlated with body fat distribution (Pearon\'s r\~0.60) \[[@B13]\]. Both WC and WHR are significantly correlated with MRI measurement of central adiposity, accepted as the "gold standard" in fat measurement. WC correlates modestly to visceral fat as measured by MRI (r^2^ = 0.6), as does WHR (r^2^ = 0.5) \[[@B13]\]. BMI, too, correlates with total adipose tissue in an individual, but it cannot capture measures of different types of fat \[[@B14]\].

For studies that aim to understand the biology of fat distribution, WHR has emerged as a particularly powerful phenotype. WHR is a measure of fat distribution that in a single continuous phenotype captures two distinct components: first, it indicates the amount of visceral fat in an individual \[[@B15]\], fat that is typically considered to be metabolically adverse; second, it captures gluteal fat, associated with protective outcomes (i.e. mitigated risk) for type 2 diabetes (T2D) and cardiovascular disease \[[@B16],[@B17]\]. Identifying anthropometric measures like WHR that can capture different types of fat is the key for understanding sexual dimorphism in fat distribution; women tend to have more subcutaneous adipose tissue (SAT) and men more visceral adipose tissue (VAT) \[[@B18]\] and genetic association studies have revealed polymorphisms specific to these tissues. Such findings emphasize the distinct role for biological differences that underpin fat distribution in males and females \[[@B19]\]. Finally, both sexes tend to have different fat depots, which affect body shape (e.g. WHR; [Figure 1](#F1){ref-type="fig"}) but not necessarily overall BMI, further demonstrating that alternative anthropometric traits (rather than BMI) are the key for genetic association studies looking to further elucidate the genetic architecture of obesity in humans.

![Sexual dimorphism in body shape and fat distribution over a human lifespan\
Sexual dimorphism in body shape and fat distribution can be observed from birth: male infants are typically born with larger head circumference and longer body length than females. In early childhood development, males remain typically heavier and taller than females. At puberty, sexual dimorphism is more marked. Females gain in fat mass whereas males gain in lean muscle mass. In early adulthood, fat deposits in women typically collect around the hips and thighs whereas in men, fat deposits collect around the inner organs and waist. After menopause in women, the body shape often shifts to a more android (square) body shape.](BSR-2016-0184Cfig001){#F1}

In addition to being a metric for body composition, distribution of adipose tissue is a phenotype closely linked to disease \[[@B20],[@B21]\]. Body fat distribution is a key measure in evaluating risk for adverse cardiometabolic outcomes, a risk that is in fact distinct from the effect that overall obesity has on disease \[[@B22]\]. Epidemiological studies of body fat distribution (measured proximally by WHR and other anthropometric measures) have revealed an association with increased risk of cardiovascular disease, T2D, stroke, hypertension and a host of other common diseases \[[@B19],[@B23]\]. The worsening obesity epidemic in the United States and around the globe has dramatically increased the incidence of these diseases. Risk of these diseases affects not only adult-age individuals, but younger ones as well. As an example, obesity is a primary risk factor for gestational diabetes mellitus (GDM) \[[@B24]\], which increases the risk of death for the mother and the child, increases risk of cardiometabolic diseases as well as increased risk of obesity later in life \[[@B25]\]. In addition to increasing risk of disease, obesity can also adversely affect fertility and reproduction. Obesity can increase the risk of infertility, miscarriage and complications during pregnancy \[[@B26],[@B27]\]. Notably, infertility in particular is associated not only with obesity, but also with being underweight. This "U-shaped" risk curve is observable in both males and females \[[@B28]\] and emphasizes the importance of studying fat distribution (as opposed to strictly excess fat) more generally.

Evidence for sexual dimorphism in fat distribution {#sec2}
==================================================

Sexual dimorphism in fat distribution: nonhumans {#sec2-1}
------------------------------------------------

The evidence for sexual dimorphism in fat distribution spans decades of epidemiological and biological data collection and observations in a variety of species. Microarray experiments in mice have demonstrated that adipose tissue mass, function and distribution are regulated by networks of sexually dimorphic genes \[[@B29],[@B30]\] and that developmental genes (defined as genes in the Genes Ontology Biological Processes database annotated for search terms including "organogenesis" and "embryonic development" \[[@B31]\]) are likely to contribute to the underpinnings of obesity and fat distribution \[[@B31]\]. In a study of mice kept on a high-fat diet for 12 weeks, microarray analysis indicated that \>1,000 genes in intra-abdominal and gonadal adipose tissue were differentially expressed between male and female mice \[[@B32]\].

Sexual dimorphism in fat distribution: humans {#sec2-2}
---------------------------------------------

The epidemiological evidence for sexual dimorphism in humans is extensive. Sexual dimorphism in body composition is already evident in infancy: males tend to be heavier than females at birth, as well as have longer bodies and larger head circumference ([Figure 1](#F1){ref-type="fig"}) \[[@B12]. In early childhood, differences between the sexes is evident in standard anthropometric measures such as height and weight, and also in specific fat measures, such as lean mass and total fat mass \[[@B33]\]. Although sexually dimorphic characteristics are more subtle in early life, sexual dimorphism in body composition and fat distribution becomes more distinct in adolescence, when males grow taller compared to females and acquire more muscle mass ([Figure 1](#F1){ref-type="fig"}) \[[@B30]\]. Additionally, although both sexes generally tend to lose mass in earlier years (approximately between ages 1 and 6), during puberty, females begin to accumulate more overall fat mass whereas males accumulate lean muscle ([Figure 1](#F1){ref-type="fig"}) \[[@B12].

By early adulthood, sexual dimorphism in fat distribution is highly evident. Female body type tends to be that of the "hourglass" or "pear" shape, with fat deposited most frequently around the hips and thighs ([Figure 1](#F1){ref-type="fig"}) \[[@B34]. This shape results from accumulation of subcutaneous fat in women that is preferentially deposited around these regions of the body \[[@B35],[@B36]\]. Pregnancy can emphasize sexually dimorphic fat distribution; an increase in body fat often occurs with pregnancy and, postpartum, there can be an increase in fat deposited around the abdomen as well \[[@B12],[@B37],[@B38]\]. In contrast, men are typically broad-shouldered and narrow-waisted \[[@B12]\], but often develop fat accumulation around the middle region later in life. Males tend to accumulate more visceral fat, which collects around the inner organs and thus appears (outwardly) to deposit most frequently around the waist ([Figure 1](#F1){ref-type="fig"}) \[[@B39].

Evidence of sexually dimorphic fat distribution is observable in humans later in life as well. As an example in women, body shape and composition often changes during menopause, when the hourglass shape in women can shift towards a more android body type, which includes increased fat deposition around the abdomen \[[@B30]\]. This shift suggests a role of sex hormones in sexual dimorphism of fat, and in particular the sexually dimorphic expression of hormones between men and women \[[@B12],[@B30]\]; the biological mechanism for this observation, however, is still unknown.

The heritability of sexual dimorphism in fat distribution {#sec3}
=========================================================

Since well before the mapping of the human genome, epidemiologists used families (and particularly twins) to estimate the heritability of fat distribution in humans. In 1987, Bouchard and colleagues \[[@B40]\] used three measures -- BMI, skinfolds and underwater body weight -- to estimate the genetic and environmental components of body composition. Their estimates provided some of the first empirical evidence that body mass and composition are, in part, biologically determined. They estimated the genetic heritability of BMI, subcutaneous fat and other fat measures, to be approximately 30% \[[@B40]\]. In 1990, a study of 265 white male twins estimated the heritabilities of WHR at 31% \[[@B41]\]. More recent estimates remain quite similar to those previously reported: overall heritability of BMI is broadly estimated from 41 to 90% in twin studies and population-level analysis, though estimates can vary greatly depending on the studied sample \[[@B42],[@B43]\]. Heritability of fat distribution phenotypes WHR and WC are estimated to be approximately 31 and 39% respectively \[[@B43]\].

Interestingly, heritability estimates for traits linked to body fat distribution are not necessarily consistent across the sexes. A recent large-scale meta-analysis of common genetic variants in humans provided heritability estimates for a number of anthropometric traits, including traits related to body fat distribution \[[@B20]\]. The study found that some anthropometric traits, including BMI, weight and height, show minimal or no distinctness when measured in only males or females ([Figure 2](#F2){ref-type="fig"}a) \[[@B20]. However, WHR and WC are accepted as better proxies for understanding fat distribution. The study found that in these fat distribution-related traits (WHR, WHR adjusted for BMI (WHRadjBMI), HIP adjusted for BMI (HIPadjBMI) and WC adjusted for BMI (WCadjBMI)), the heritability calculations in males and females were quite distinct ([Figure 2](#F2){ref-type="fig"}) \[[@B20]. An additional study of metabolic-related traits in the Dutch Twins Registry further demonstrated sexual dimorphism in fat distribution traits: in younger participants in the study (age \<42 years) the heritability of WC and WHR was approximately 30--35% in males, in contrast with 45--50% heritability in females \[[@B43]\]. An additional study of female twins estimated the heritability of WHR to be 36--61% and the heritability of WC to be higher, at 72--82% \[[@B44]\]. These findings indicate that some traits (e.g., BMI) have highly overlapping genetic architectures between males and females, whereas other traits (e.g. WHRadjBMI and HIPadjBMI) have somewhat (though not entirely) distinct genetic architectures in males and females. Thus, there are likely biological pathways unique to or differentially expressed in males and females that contribute to fat distribution. The sexual dimorphism in these heritabilities also indicates that risk for diseases associated with obesity or fat distribution may also have biological drivers that are specific or differentially regulated in one sex compared with the other.

![The genetics of sexually dimorphic traits that measure fat distribution\
(**a**) A number of anthropometric traits, such as height, weight, BMI, HIP and WC have been demonstrated to have similar genetic heritability estimates between males and females. Additional traits, however, have been shown to be sexually dimorphic. In particular, heritability calculations indicate that WHR, WHRadjBMI, WCadjBMI and HIPadjBMI are sexually dimorphic; the heritability estimates for these traits are systematically higher in females (yellow) compared with males (purple). These findings suggest a stronger genetic contribution to these traits in females, and biological mechanisms that are different or differentially expressed between males and females. (**b**) Several sexually dimorphic loci associated with anthropometric and fat distribution traits have been implicated through genome-wide association studies (GWAS). Here, we annotate the chromosomal position of loci that appear at genome-wide significance in female-only (yellow) or male-only (purple) analyses. Loci that have significantly different *P*-values in females compared with males (or vice versa) appear in bold. All loci annotated here were discovered in WHRadjBMI except for loci discovered in HIP (four-piece diamond), HIPadjBMI (asterisks), WCadjBMI (triangles) and WHR (solid diamonds). Note that the genes annotated here reside closest to the associated SNP but are not necessarily causal. Data from the figure were drawn from Tables 1 and 2 in \[[@B20]\].](BSR-2016-0184Cfig002){#F2}

Noticeable in the data we present here, and in many heritability calculations, the estimates of genetic heritability in complex traits can be broad and imprecise. Biases, including sample ascertainment and assumptions regarding shared environment, flaws in data interpretation and limited sample size can all influence the precision of heritability estimates \[[@B45]\]. Nevertheless, various lines of epidemiologic and genetic evidence point to potentially distinct biological architectures in traits related to body fat composition between the sexes. Further, sexually dimorphic biological mechanisms have already been observed in males and females, providing an additional layer of evidence for sex-specific effects on body fat distribution. For example, studies of mRNA and miRNA expression in humans have revealed sexually dimorphic patterns in tissue of the abdomen as well as gluteal adipose \[[@B46],[@B47]\].

Sexual dimorphism in fat distribution: the genetic evidence {#sec4}
===========================================================

Genome-wide association studies in fat distribution traits {#sec4-1}
----------------------------------------------------------

Genome-wide association studies (GWAS) have been a powerful tool in identifying common genetic variants (SNPs with a minor allele frequency (MAF) \> 1%) associated with common, complex diseases and traits. By interrogating SNPs across the span of the human genome and examining frequency differences in SNPs that are associated with phenotypic outcome, GWAS have yielded hundreds of loci associated with thousands of traits \[[@B48]\]. Consortia centred around fat distribution traits including WC, HIP and WHR have assembled genotyping data in thousands of samples and revealed over 100 loci that harbour common-variant associations to these traits \[[@B13],[@B14],[@B20],[@B21]\]. A number of large-scale GWAS have sought to identify common SNPs influencing overall obesity through BMI \[[@B49]\], the largest and most recent of which analysed more than 339,000 individuals and identified 97 loci associated with the trait \[[@B21]\]. Other GWAS have focused on body fat percentage (BF%) as a phenotypic outcome. A GWAS of BF% in \>100,000 individuals revealed 12 loci reaching genome-wide significance (*P* \< 5 × 10^−8^) \[[@B52]\]. Several of these signals overlapped signals found in GWAS of BMI, but conferred stronger effects in BF%, suggesting the importance of their role in adiposity specifically (as opposed to BMI, which measures both fat and lean mass) \[[@B52]\]. A GWAS of WHRadjBMI in \>224,000 samples revealed 49 significantly associated loci, many of which contained genes expressed in adipose tissue \[[@B20]\]. GWAS have also revealed potential overlapping genetic architectures between monogenic and population-level forms of obesity. Although mutations in the *MC4R* gene, for example, are the leading cause of monogenic obesity in humans, this locus has also revealed through GWAS to contain common, BMI-increasing polymorphisms segregating in population-representative adult samples \[[@B53]\].

Sexually dimorphic loci discovered through GWAS and biological insights {#sec4-2}
-----------------------------------------------------------------------

Beyond implicating key risk loci, GWAS have been helpful in highlighting sexually dimorphic loci in fat distribution traits. Of the 49 associated loci discovered in the most recent WHRadjBMI GWAS, 20 of them (approximately 40%) showed significant sexual heterogeneity \[[@B20]\]. Incredibly, 19 of these 20 dimorphic loci conferred a stronger effect on women as compared with men ([Figure 2](#F2){ref-type="fig"}b) \[[@B20]. An intricate sex-specific genetic architecture was discovered at two loci, *HOXC6--HOXC13* and *TBX15--WARS2--SPAG17*. Specifically, conditional analysis in these regions revealed female- and male-specific signals. Of the three independent associations in the *HOXC6--HOXC13* region, one was found to be female-specific (rs1443512, *P*~conditional~ = 1.1 × 10^−14^); in contrast, in the *TBX15--WARS2--SPAG17* region, one of the four independent signals was male-specific (rs1106529, *P*~conditional~ = 4.8 × 10^−9^) \[[@B20]\]. These observations suggest potentially distinct biological mechanism between the sexes as well as common mechanisms which might be influenced by different variants (i.e. genetic heterogeneity). These findings affirm the hypothesis that the sexual dimorphism of fat distribution is at least partially inherited and biologically regulated.

A small number of GWAS studies have focused specifically on uncovering sexually dimorphic loci associated with fat distribution. Only analyses in waist-related phenotypes (as opposed to other anthropometric measures) revealed significant results. In an analysis of 270,000 individuals, seven loci showed genome-wide significant sexual dimorphism: near growth factor receptor-bound protein 14 (*GRB14*)/*COBLL1*,*LYPLAL1*/*SLC30A10, VEGFA, ADAMTS9, MAP3K1, HSD17B4 and PPARG* ([Figure 2](#F2){ref-type="fig"}b) \[[@B30]*.* The loci demonstrated to have a stronger effect in women contained a number of genes that are known to be associated with lipid traits or insulin resistance \[[@B14],[@B20],[@B30]\]. One locus (index SNP rs10195252, *P =* 5.9 × 10^−15^) contains the gene *GRB14* \[[@B20]\], which encodes a protein necessary for insulin signalling regulation. The implication of female-specific associations in *GRB14* is not new; additional variants in this region have been discovered previously in WHRadjBMI, and analyses in a number of metabolic phenotypes including blood lipids, SAT and T2D, have also revealed associated variants \[[@B14],[@B30],[@B54],[@B55]\]. Additionally, the sexually dimorphic signal at *GRB14* replicated in a study of African-ancestry individuals \[[@B23]\], suggesting that the signal is constant across populations, as has been true for GWAS findings in other diseases \[[@B56]\]. Animal models have added additional empirical evidence for the potential role of *GRB14* in obesity: specifically, an analysis of *GRB14* expression in adipose tissue found a negative correlation between insulin sensitivity and gene expression \[[@B57]\] in both rodents and humans, and Grb14 knockout mice showed better control of glucose levels (called glucose homoeostasis) \[[@B58]\]. Collectively, the genetic and biological evidence indicate that *GRB14* has a key role in adipose distribution, and understanding the biological role of *GRB14* may yield insights into potential therapeutics used to treat the rapidly growing obesity epidemic.

In addition, the gene *ADAMTS9*, which lies in a locus discovered through GWAS of WHRadjBMI, contains variants that have a stronger effect in women than in men (rs2371767, *P*~men~ = 0.035 and *P*~women~ = 1.2 × 10^−25^ \[[@B20]\]). *ADAMTS9* is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of proteins. These proteins serve a number of roles, including controlling organ maturation and development as well as inhibiting blood vessel formation \[[@B59]\]. Additional GWAS have revealed more information about the potential role for *ADAMTS9*: a variant in *ADAMTS9* (rs6795735, MAF = 59.4%, linkage disequilibrium (LD) to WHRadjBMI SNP rs2371767 = 0.31, HapMap 2 samples of Northern and Western European ancestry living in Utah (the CEU population) \[[@B60]\]) was also found to be nominally associated with decreased high-density lipoprotein (HDL) (rs6795735, *Z*-score = --2.5, *P =* 0.01) and T2D risk (rs6795735, OR = 1.12, *P* = 0.002) through GWAS, but not with BMI \[[@B14],[@B61]\].

The lack of sexually dimorphic loci in body fat percentage and BMI {#sec4-3}
------------------------------------------------------------------

Some GWAS of overall obesity have revealed a notable lack of sexual dimorphism. For example, of the four loci discovered by the recently discussed GWAS in BF% (in or near *COBLL1/GRB14, IGF2BP1, PLA2G6, CRTC1*) \[[@B52]\] and in the most recent GWAS of obesity as measured by BMI \[[@B21]\] only a very small number of these overall obesity loci exhibited sexual dimorphism (approximately 3--5%) \[[@B21],[@B52]\]. There are several potential explanations for the apparent lack of sexual dimorphism in BMI and BF% loci compared with WHR. First, biological pathways for fat distribution traits WHR and WC are likely to be quite distinct from BMI. Analysis of the loci implicated by the latest GWAS in BMI revealed a major neuronal component underpinning the trait \[[@B21]\]. In contrast, WHR and WC loci revealed through GWAS have revealed that these traits are more likely to be influenced by early development and/or differentiation of adipocytes \[[@B20],[@B21]\]. These findings again point to a striking difference across the many facets of obesity and raise the possibility that different organs are differentially susceptible for sexually dimorphic effects. Further, these findings reflect important and fundamental physiological differences between men and women (discussed below).

Discussion {#sec5}
==========

Understanding the underlying biological mechanisms and downstream effects of sexually dimorphic associations with body fat distribution is a crucial step in understanding disease risk and pathogenesis. Further, unravelling the genetic underpinnings of disease and the related sexual dimorphism, may help reveal therapeutic targets or diagnostically relevant mechanisms used to predict or treat obesity in men or women specifically. One such example is *PPARG*, a gene found to be associated with T2D and monogenic forms of severe obesity and severe digenic insulin resistance \[[@B62],[@B63]\]. An SNP in *PPARG* associated with WHRadjBMI exhibits sexual dimorphism, with a significantly stronger effect in women (β~women~ = 0.035, β~men~ = 0.005) \[[@B20]\]. Additionally, a drug trial in PPARG-agonist therapy revealed sexual dimorphism in the response of patients with T2D, indicating that insulin resistance may have (partially) distinct mechanisms in men and women \[[@B64]\]. The findings at *PPARG*, and potentially additional findings at other sexually dimorphic loci revealed through ongoing functional work, may help in our movement towards precision medicine. Clinical trials for obesity treatments or treatments of obesity-related disease, for example, may be improved by stratifying on sex.

Very few GWAS (or large-scale epidemiologic studies) of complex traits and common diseases have explicitly and thoroughly investigated the potential role for sexual dimorphism in the underlying biology of disease. This phenomenon is likely due in part to statistical power; performing sex-specific analyses require reducing the sample size of a study by half, thus also reducing statistical power to reveal an association of subtle effect \[[@B65]\], typical for common-variant associations discovered in common disease \[[@B56]\]. Large-scale consortia and biobanking \[[@B66]\] have now enabled GWAS of common diseases at an unprecedented scale; the number of samples worldwide that have undergone genotyping using SNP arrays now number into millions \[[@B21],[@B56],[@B67]\]. Though sex-specific analyses will still require a loss in power compared with analysing both sexes jointly, this amassing of samples now enables us to investigate sexual dimorphism in obesity and related traits in samples numbering in tens or hundreds of thousands. Such studies may reveal additional sexually dimorphic risk loci associated with not only obesity, but to an array of obesity-related traits and diseases such as cardiovascular disease \[[@B22]\], metabolic diseases \[[@B17]\], schizophrenia \[[@B21]\], fertility \[[@B26]\], irritable bowel syndrome \[[@B21]\] and Alzheimer's disease \[[@B21],[@B27]\].

Further, genetics and genomics will remain powerful approaches in understanding and treating diseases. Additional GWAS that focus on sex-specific risk can reveal biological information beyond newly discovered risk loci. A number of publicly available software and resources are helping to identify \"credible sets\" of SNPs in GWAS loci that are most likely to drive observed association signals \[[@B68]\], integrate expression information to identify expression quantificative trait loci (eQTLs) \[[@B71]\] and include genome-folding information to disentangle the role of regulatory variation \[[@B72]\]. These tools, in combination with improved functional annotation of the genome \[[@B73]\] and increasingly dense sequencing-based imputation reference panels \[[@B7],[@B76]\], will help further advance our understanding of common disease risk from associated locus to biological mechanism. Additionally, breakthroughs in single-cell sequencing \[[@B77]\], RNA sequencing \[[@B78],[@B79]\], and gene editing \[[@B80]\] allow for tissue-specific investigations of gene variants or changes in expression at genes or variants associated with disease. This massive collection and integration of 'omics' data will help in completing our understanding of gene networks or regulatory mechanisms that contribute to disease risk or progression, and allow us to understand disease severity in cell, tissue and developmental stage specific settings.

As the obesity epidemic has now reached global proportions, fat distribution and obesity are worthy of scientific study more than ever. The epidemic brings with it an increased prevalence of diseases that are epidemiologically and biologically linked to obesity, such as cardiovascular and metabolic diseases; these diseases are often chronic, can be fatal, and create a profound burden in terms of diminished quality of life, societal cost (e.g., lost work productivity) and healthcare-related monetary costs, which amounts to billions of dollars every year in the United States and elsewhere \[[@B81],[@B82]\]. Due to the environmental components that influence obesity, such as diet and exercise, information on how to curb the epidemic is often drawn from a wide range of sources, including incomplete or biased information. Diet studies, for example, typically rely on survey information, which can be inaccurate or incomplete. Exercise studies are heavily biased towards examining male participants; this bias greatly limits our understanding of the effect of exercise on obesity in women \[[@B83]\], even though women are equally affected by the epidemic \[[@B84]\]. Given the various sources of information around obesity and its treatment and the increasing number of individuals affected by the disease, obesity deseves not only our attention but the utmost scientific rigor as well. Sexual dimorphism and its role in fat distribution, made clear by epidemiologic and genetic studies, will be a key part of unravelling the biological risk factors of obesity in a rigorous and complete manner. In particular, further disentangling the sexual dimorphism at loci associated with fat distribution, as well as designing studies of obesity that explicitly focus on females or males only, will yield insights into the biological signatures of disease that are sex-specific. Such information will improve precision medicine, inform sex-stratified clinical trials, and help in moving us towards treating and ultimately stemming the obesity epidemic worldwide.
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